Time-robust myocardial [<sup>68</sup>Ga]Ga-FAPI PET biomarker reflects aortic stenosis severity and predicts post-TAVI outcomes.
prospective_cohort · Level II
Where this comes from
- Record sourced from PubMed, PMID 41692852.
- Also identified by DOI 10.1007/s00259-026-07815-4 and PMC identifier 13121330.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
Aortic stenosis (AS) induces myocardial remodeling and fibroblast activation, yet modifiable biomarkers capable of capturing active fibrogenesis and predicting post-transcatheter aortic valve implantation (TAVI) recovery are currently scarce. Fibroblast activation protein (FAP)-targeted PET serves as a noninvasive tool to visualize activated fibroblasts in vivo. We evaluated a time-robust, blood-pool-normalized myocardial [<sup>68</sup>Ga]Ga-FAPI PET imaging biomarker that reflects AS burden and predicts outcomes after TAVI. Nineteen patients with severe symptomatic AS underwent [<sup>68</sup>Ga]Ga-FAPI-04 PET/CT at 60, 70, and 120 min. Using an in-house semi-automatic pipeline, the left ventricular (LV) myocardium was segmented, and regions of elevated fibroblast activity (EFM) were delineated using a blood-pool-anchored, time-point-specific threshold. We quantified myocardial SUV<sub>mean</sub>, blood-pool SUV<sub>mean</sub>, and a normalized myocardium-to-blood index, TBR(EFM), and assessed associations with N-terminal pro-brain natriuretic peptide (NT-proBNP) and left-ventricular ejection fraction (LVEF). One-year outcomes (n = 11) were assessed using a predefined composite clinical response. Blood-pool SUV<sub>mean</sub> declined from 60 to 120 min, whereas myocardial SUV<sub>mean</sub> decreased less, yielding stable TBR(EFM) across time points (60/70/120 min: 2.2 ± 0.8, 2.1 ± 0.9, 2.3 ± 0.9; ANOVA p = 0.596). By contrast, myocardial SUV<sub>mean</sub> fell from 3.8 ± 0.7 (60 min) to 2.1 ± 0.9 (120 min; p < 0.001). TBR(EFM) correlated with NT-proBNP at all time-points (60 min r = 0.65, p = 0.007; 120 min r = 0.72, p = 0.003), whereas SUV<sub>mean</sub> did not (60 min p = 0.576; 120 min p = 0.109). Baseline TBR(EFM) was significantly lower in one-year responders than non-responders (1.7 ± 0.2 vs. 2.9 ± 0.9; p = 0.013), with separation present at each time point (p < 0.05). Higher baseline TBR(EFM) associated with lower reductions in NT-proBNP at one year (p < 0.05). Myocardial [<sup>68</sup>Ga]Ga-FAPI TBR may provide a time-robust index of active fibroblast signaling that relates to myocardial hemodynamic stress and stratifies one-year clinical response after TAVI. A single 60-minute acquisition with TBR quantification may be sufficient for myocardial [<sup>68</sup>Ga]Ga-FAPI assessment. These hypothesis-generating findings require validation in larger, multicenter cohorts.
Medical subject headings
- Aortic Valve Stenosis
- Positron Emission Tomography Computed Tomography
- Transcatheter Aortic Valve Replacement
- Serine Endopeptidases
- Gelatinases